You are here: Industry Insights > SARS-CoV-2

News List

Thermo Fisher Scientific Extends SARS-CoV-2 GlobalAccess Sequencing Program americanpharmaceuticalreview
January 21, 2021
Thermo Fisher Scientific has announced an extension of its SARS-CoV-2 GlobalAccess Sequencing Program to provide additional units of the Ion Torrent Genexus System and Ion GeneStudio S5 Series sequencers at a subsidized price to further support global ...
Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody JMB2002 prnasia
January 20, 2021
On January 15, Jemincare Group, a Chinese pharmaceutical company, announced that it has initiated the phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody (JMB2002).
ARUP Sequencing Specimens Able to Detect the UK Variant of COVID-19 americanpharmaceuticalreview
January 20, 2021
ARUP Laboratories announced it is sequencing variants of SARS-CoV-2 in specimens positive for COVID-19 to enable detection of the more contagious "United Kingdom (UK) variant" of the virus.
ImmunityBio Simulations give clue to why South African strain of SARS-CoV-2 is rapidly spreading expresspharma
January 20, 2021
Using Molecular Dynamic (MD) simulation, ImmunityBio scientists assessed the affinity of mutated spike receptor binding domain (RBD) of SARS-CoV-2 to its receptor on human cells, ACE2.
South African variant of SARS-CoV-2 should be more focus from governments: GobalData expresspharma
January 20, 2021
The South African variant shows more spike protein mutations than the UK variant, which might allow the virus to escape the immune protection provided by vaccination or prior infection.
Grifols Begins COVID-19 Plasma Treatment Trial contractpharma
January 19, 2021
Treatment could be used for people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease, complementing the vaccine.
Pregnant, lactating women should not be given COVID-19 vaccine now: Health ministry expresspharma
January 15, 2021
In a letter to all states and Union territories, the ministry highlighted that under the emergency use authorisation, coronavirus vaccination is indicated only for 18 years and above.
First patient dosed with COVI-VAC, an intranasal COVID-19 vaccine candidate europeanpharmaceuticalreview
January 14, 2021
The trial will assess the safety and immunogenicity of a single intranasal dose of COVI-VAC in 48 healthy volunteers in the UK.
Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization prnewswire
January 13, 2021
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS® SARS-CoV-2 Antigen Test, designed to detect active infection, has become the first high-volume COVID-19 antigen test to receive ...
FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation americanpharmaceuticalreview
January 12, 2021
The U.S. Food and Drug Administration (FDA) is alerting clinical laboratory staff and health care providers that the FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page